The clinical characteristics and laboratory findings of the 17 Vietnamese XLA patients with BTK mutations were similar to those observed in Western countries, with episodes of pneumonia reported by 80% of the Vietnamese patients, 62% of US patients (7), 100% of patients from the Netherlands (18), and 77% of patients from China (8). This evidence concerns the gene BTK and susceptibility to pneumonia measurement.